Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.

Data reviewed in this article demonstrate that both interferon-ß-1a (IFNß-1a) and interferon-ß-1b (IFNß-1b) show a dose-response relationship in multiple sclerosis at current clinical doses.

including production of interferon (IFN)-b,when delivered to cells. The investigators showed that RAR-induced cell death is potentiated by addition of recombinant IFN-b. Based on the current study ...

Researchers have uncovered critical mechanisms linked to metabolic insufficiencies that underlie plasmacytoid dendritic cell ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...

Tests for hepatitis B surface antigen and anti-hepatitis C ... The patient was started on pegylated interferon α2a monotherapy given subcutaneously once weekly to treat her HCV infection.

EULAR - The European Alliance of Associations for Rheumatology - held its 2024 congress in Vienna, where new work was unveiled on the potential value of the blood interferon signature in pediatric ...

This makes BESREMi® the best investigated interferon in clinical trials in this indication as documented in the major relevant guidelines 1. AOP Health had acquired the rights for both BESREMi ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...